谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Table S3 from HER3 Augmentation Via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer

Kimio Yonesaka,Junko Tanizaki,Osamu Maenishi,Koji Haratani,Hisato Kawakami,Kaoru Tanaka,Hidetoshi Hayashi,Kazuko Sakai,Yasutaka Chiba,Asuka Tsuya,Hiroki Goto,Eri Otsuka,Hiroaki Okida,Maki Kobayashi,Ryoto Yoshimoto,Masanori Funabashi,Yuuri Hashimoto,Kenji Hirotani,Takashi Kagari,Kazuto Nishio,Kazuhiko Nakagawa

crossref（2023）

引用 0|浏览8
暂无评分
摘要
Hallmarks of with/without Beyond PD treatment with EGFR TKI group
更多
查看译文
关键词
EGFR Mutations,Tumor Markers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要